Healthcare Finance News March 1, 2024
Jeff Lagasse

Traditional monitoring methods can incur unnecessary costs and potentially extra steps, Signify says.

Signify Health, a subsidiary of CVS Health, will add a heart arrhythmia test to its Diagnostic and Preventive Services offering. The move is intended to broaden Signify’s range of in-home services designed to support earlier detection, diagnosis and management of various medical conditions.

The prevalence of heart arrhythmias, or irregular heartbeat, is expected to grow because of the aging U.S. population. Atrial Fibrillation is the most common arrhythmia, with an estimated one-third of adults being asymptomatic and between 1.26 and 1.52 million cases being undiagnosed, a pair of studies show.

People with undiagnosed heart arrhythmias struggle with symptoms such as chest pain, rapid and irregular heartbeat,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Home, Patient / Consumer, Post-Acute Care, Provider
University of Rochester Medical Center plans hospital-at-home program
Hospital-at-Home: Bridging Inpatient and Remote Care
Why Saint Luke's plans to expand hospital at home
Meet the Company Developing an At-Home Test to Replace the Pap Smear
AdventHealth Rolls Out New Hospital-At-Home Program

Share This Article